CAI
Caris Life Sciences, Inc. Common Stock
NASDAQ: CAI · HEALTHCARE · BIOTECHNOLOGY
$17.77
-3.63% today
Updated 2026-04-29
Market cap
$5.02B
P/E ratio
—
P/S ratio
6.19x
EPS (TTM)
$-3.22
Dividend yield
—
52W range
$16 – $43
Volume
2.3M
Caris Life Sciences, Inc. Common Stock (CAI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61.59M | $18.61M | $64.87M | $83.14M | $65.26M | $77.90M | $125.71M | $173.93M | $212.41M | $227.59M | $249.67M | $294.35M | $348.39M | $432.10M | $416.54M | $294.01M | $258.49M | $306.13M | $412.26M | $812.03M |
| Revenue growth (YoY) | — | -69.8% | +248.6% | +28.2% | -21.5% | +19.4% | +61.4% | +38.4% | +22.1% | +7.1% | +9.7% | +17.9% | +18.4% | +24.0% | -3.6% | -29.4% | -12.1% | +18.4% | +34.7% | +97.0% |
| Cost of revenue | — | $1.17M | $4.04M | $4.87M | $8.72M | $6.17M | $5.51M | $48.35M | $67.11M | $77.98M | $123.76M | $156.86M | $179.11M | $218.47M | $216.03M | $109.86M | $178.46M | $216.82M | $233.48M | $272.87M |
| Gross profit | $61.59M | $17.44M | $60.83M | $78.27M | $56.55M | $71.73M | $120.19M | $125.57M | $145.30M | $149.61M | $125.91M | $137.50M | $169.29M | $213.63M | $200.51M | $184.16M | $80.02M | $89.31M | $178.78M | $539.17M |
| Gross margin | 100.0% | 93.7% | 93.8% | 94.1% | 86.6% | 92.1% | 95.6% | 72.2% | 68.4% | 65.7% | 50.4% | 46.7% | 48.6% | 49.4% | 48.1% | 62.6% | 31.0% | 29.2% | 43.4% | 66.4% |
| R&D | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $101.27M | $116.88M | $113.92M | $45.31M |
| SG&A | — | — | — | — | — | — | — | — | $19.26M | — | $27.62M | $35.68M | $42.70M | $50.30M | $52.70M | $27.31M | $156.15M | $151.95M | $173.56M | $224.97M |
| Operating income | $24.14M | $12.05M | $39.94M | $44.29M | $22.83M | $36.97M | $64.30M | $90.61M | $101.41M | $97.03M | $68.09M | $65.96M | $105.67M | $148.78M | $130.28M | $139.09M | $-315.76M | $-319.55M | $-257.12M | $45.11M |
| Operating margin | 39.2% | 64.7% | 61.6% | 53.3% | 35.0% | 47.5% | 51.1% | 52.1% | 47.7% | 42.6% | 27.3% | 22.4% | 30.3% | 34.4% | 31.3% | 47.3% | -122.2% | -104.4% | -62.4% | 5.6% |
| EBITDA | $39.02M | $14.94M | $51.52M | $11.47M | $40.72M | $59.62M | $112.74M | $151.83M | $175.40M | $181.51M | $181.36M | $159.27M | $223.51M | $283.31M | $248.30M | $254.46M | $-245.89M | $-260.80M | $-182.95M | $11.38M |
| EBITDA margin | 63.4% | 80.3% | 79.4% | 13.8% | 62.4% | 76.5% | 89.7% | 87.3% | 82.6% | 79.8% | 72.6% | 54.1% | 64.2% | 65.6% | 59.6% | 86.5% | -95.1% | -85.2% | -44.4% | 1.4% |
| EBIT | $24.16M | $12.07M | $40.74M | $-6.06M | $21.79M | $37.22M | $77.41M | $102.08M | $106.99M | $102.68M | $67.12M | $52.59M | $110.25M | $159.83M | $134.37M | $143.81M | $-294.15M | $-309.81M | $-231.87M | $-11.23M |
| Interest expense | $7.80M | $3.71M | $10.41M | $9.35M | $4.31M | $5.28M | $16.14M | $28.80M | $36.01M | $35.21M | $36.03M | $42.75M | $53.05M | $78.34M | $79.16M | $61.56M | $26.68M | $31.61M | $50.02M | $56.85M |
| Income tax | $6.38M | $3.12M | $11.10M | $11.55M | $3.92M | $3.56M | $11.08M | $9.82M | $7.06M | $7.19M | $4.25M | $3.84M | $-14.86M | $2.89M | $4.19M | $1.80M | — | — | — | — |
| Effective tax rate | 39.0% | 37.3% | 36.6% | -75.0% | 22.4% | 11.1% | 18.1% | 13.4% | 9.9% | 10.7% | 13.7% | 39.1% | -26.0% | 3.5% | 11.9% | 6.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $9.99M | $5.23M | $19.23M | $-26.95M | $13.56M | $28.38M | $50.19M | $63.47M | $63.93M | $60.27M | $26.84M | $6.00M | $72.06M | $78.60M | $31.01M | $27.73M | $-320.83M | $-341.42M | $-281.89M | $-537.96M |
| Net income growth (YoY) | — | -47.6% | +267.6% | -240.1% | +150.3% | +109.4% | +76.8% | +26.5% | +0.7% | -5.7% | -55.5% | -77.7% | +1101.6% | +9.1% | -60.5% | -10.6% | -1256.8% | -6.4% | +17.4% | -90.8% |
| Profit margin | 16.2% | 28.1% | 29.6% | -32.4% | 20.8% | 36.4% | 39.9% | 36.5% | 30.1% | 26.5% | 10.7% | 2.0% | 20.7% | 18.2% | 7.4% | 9.4% | -124.1% | -111.5% | -68.4% | -66.2% |